Just About Anyone Can Sell You GLP-1s Online Now
The rise of 'turnkey' telehealth infrastructure companies is allowing non-medical brands to quickly launch virtual clinics for prescription drugs like GLP-1s. This trend lowers the barrier to entry for businesses to offer specialized medical services, raising concerns about the ease of access to potent medications.
Why it matters
It highlights the rapid commercialization of healthcare and the potential regulatory challenges posed by non-traditional entities entering the medical space.
Plus, it was easy to find help: A company called WhiteLabelMD handles customer service, provides software, and connects patients with clinicians who prescribe drugs like semaglutide and tirzepatide. “We wouldn’t have gotten into this if we had to build it all from scratch,” Kurtzig says.
The article presents a factual overview of a business trend without taking a strong moral stance, though it notes the ease of access as a potential concern.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in